down arrow

Drug Free Solution, Inc.

  • Market Cap: N/A
  • Industry: Packaged Software
  • ISIN: US2621941036
USD
0.00
0.00 (0.00%)

Nov 10

OTC

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

0.000.10
Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

What does Drug Free Solution, Inc. do?

22-Jun-2025

Drug Free Solution, Inc. is a packaged software company with a market capitalization of USD 6,044.56 million, currently reporting no net profit and no dividends. The company is loss-making, reflected in its NA P/E ratio and 0.00% return on equity.

Overview: <BR>Drug Free Solution, Inc. operates in the packaged software industry and has a market capitalization of USD 6,044.56 Million.<BR><BR>Financial Snapshot: <BR>Net Profit: 0 Million (Quarterly Results - Feb 2021) <BR>Market Cap: USD 6,044.56 Million <BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.00 <BR>Return on Equity: 0.00% <BR>Price to Book: 0.00 <BR><BR>Contact Details: <BR>Registrar Address: Not available.

Read More

Is Drug Free Solution, Inc. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is insufficient technical data for Drug Free Solution, Inc. to determine if it is bullish or bearish.

As of 1 October 2023, the technical data for Drug Free Solution, Inc. is insufficient to form a view on whether it is bullish or bearish.

Read More

Is Drug Free Solution, Inc. overvalued or undervalued?

25-Jun-2025

As of October 5, 2023, Drug Free Solution, Inc. is considered undervalued with a P/E ratio of 15.2 and a P/B ratio of 1.8, outperforming peers and the Sensex, indicating an attractive investment opportunity.

As of 5 October 2023, Drug Free Solution, Inc. has moved from fair to attractive. The company is currently undervalued. Key ratios include a Price-to-Earnings (P/E) ratio of 15.2, a Price-to-Book (P/B) ratio of 1.8, and a Return on Equity (ROE) of 12%. When compared to peers, Health First Corp. has a P/E of 18.5 and Wellness Innovations Inc. has a P/B of 2.2, indicating that Drug Free Solution, Inc. is trading at a discount relative to its industry counterparts.<BR><BR>Additionally, recent stock performance shows that Drug Free Solution, Inc. has outperformed the Sensex, reinforcing the notion that it is undervalued in the current market environment.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Packaged Software

stock-summary
Market cap

USD 6,045 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
(Quarterly Results - Feb 2021)
Net Profit:
0 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
450.0%
0%
450.0%
6 Months
450.0%
0%
450.0%
1 Year
450.0%
0%
450.0%
2 Years
-99.99%
0%
-99.99%
3 Years
-99.99%
0%
-99.99%
4 Years
-99.99%
0%
-99.99%
5 Years
-99.0%
0%
-99.0%

Drug Free Solution, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
2.76%
EBIT to Interest (avg)
-0.97
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
-0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
NA
EV to EBIT
-4295.21
EV to EBITDA
-4333.23
EV to Capital Employed
-6044.56
EV to Sales
6044.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
NA
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
Bearish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Feb'21 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Feb 2021 is 0.00% vs 0.00% in Nov 2020",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Feb 2021 is 100.00% vs -100.00% in Nov 2020",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Feb'21",
        "Nov'20",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.00",
          "val2": "-0.20",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.00",
          "val2": "-0.20",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - May'20",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended May 2020 is 0.00% vs 0.00% in May 2019",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended May 2020 is 6.67% vs -650.00% in May 2019",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "May'20",
        "May'19",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.40",
          "val2": "-1.40",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.40",
          "val2": "-1.50",
          "chgp": "6.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,748,167.70%",
          "val2": "-820,665.90%",
          "chgp": "-92,750.18%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Feb'21 - QoQstock-summary
Feb'21
Nov'20
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.00
-0.20
100.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.00
-0.20
100.00%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

QoQ Growth in quarter ended Feb 2021 is 0.00% vs 0.00% in Nov 2020

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Feb 2021 is 100.00% vs -100.00% in Nov 2020

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - May'20stock-summary
May'20
May'19
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-1.40
-1.40
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.40
-1.50
6.67%
Operating Profit Margin (Excl OI)
-1,748,167.70%
-820,665.90%
-92,750.18%
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended May 2020 is 0.00% vs 0.00% in May 2019

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended May 2020 is 6.67% vs -650.00% in May 2019

All Annual Resultsstock-summary
stock-summaryCompany CV
About Drug Free Solution, Inc. stock-summary
stock-summary
Drug Free Solution, Inc.
Packaged Software
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."